US Orthobiologics Market (Growth Factor, DBM, Bone Substitute, Cell-based Matrices, Machined Bone, Allograft Bone): Industry Analysis & Outlook (2019-2023)

US Orthobiologics Market (Growth Factor, DBM, Bone Substitute, Cell-based Matrices, Machined Bone, Allograft Bone): Industry Analysis & Outlook (2019-2023)

Orthobiologics are the biologically derived materials from the body to promote the repair and regeneration of musculoskeletal tissues. When they are used in higher concentrations than normally present in the body, they can potentially help speed up the healing process. The substances which are considered to be Orthobiologics are: growth factors, DBM, cell based matrices, machined bone, bone substitute and others. These are capable of bone formation and encourage healing of fractures, nonunion, and repairing defects of various traumatic and non-traumatic conditions of skeletal system.

The U.S. Orthobiologics Market has, lately, become concentrated to sustain the growth by introducing various medical innovations. The healthcare and medical sector is rapidly growing due to increasing healthcare problems amongst people, especially old age people. The increased demand for growth factors and DBM from end- users segments such as hospitals and medical centers had a major contribution in the growth of the U.S. Orthobiologics market.

The growth of the market is attributable to factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures.

The global Orthobiologics market is dominated by four key players: Medtronic, Johnson and Johnson, Sanofi S.A. and Zimmer Biomet. Whereas, the U.S. Orthobiologics market is majorly ruled by Medtronic, Johnson and Johnson, Stryker Corporation and NuVasive Inc. All these leading players have a major contribution in the growth of global as well the U.S. Orthobiologics market. Their effective strategy formulation and implementation has helped in the expansion of the healthcare sector to a great extent.


1. Market Overview
1.1 Orthobiologics
1.2 Essentials for Orthobiologics
Table 1: Essentials for Orthobiologics
1.3 Types of Orthobiologics
Types of Orthobiologics
1.4 Applications of Different Orthobiologics
Table 3: Applications of Different Orthobiologics
1.5 Orthobiologics Procedures
Table 4: Orthobiologics Procedures
1.6 Advantages and Disadvantages of Bone Grafts and Substitutes
Table 5: Advantages and Disadvantages of Bone Grafts and Substitutes
2. Global Orthobiologics Market Analysis
2.1 Global Orthobiologics Market Forecast by Value
Table 6: Global Orthobiologics Market Forecast by Value (2018-2023)
2.2 Global Orthobiologics Market Value by Region
Table 7: Global Orthobiologics Market Value by Region (2018)
3. The U.S. Orthobiologics Market Analysis
3.1 The U.S. Orthobiologics market by Value
Table 8: The U.S. Orthobiologics Market by Value (2014-2018)
3.2 The U.S. Orthobiologics Market Forecast by Value
Table 9: The U.S. Orthobiologics Market Forecast by Value (2019-2023)
3.3 The U.S. Orthobiologics Market Value by Product
Table 10: The U.S. Orthobiologics Market Value Share by Segments (2018)
3.3.1 The U.S. Growth Factors Market by Value
Table 11: The U.S. Growth Factors Market by Value (2014-2018)
3.3.2 The U.S. Growth Drivers Market Forecast by Value
Table 12: The U.S. Growth Factors Market Forecast by Value (2019-2023)
3.3.3 The U.S. DBM Market by Value
Table 13: The U.S. DBM Market by Value (2014-2018)
3.3.4 The U.S. DBM Market Forecast by Value
Table 14: The U.S. DBM Market Forecast by Value (2019-2023)
3.3.5 The U.S. Bone Substitute Market by Value
Table 15: The U.S. Bone Substitute Market by Value (2014-2018)
3.3.6 The U.S. Bone Substitute Market Forecast by Value
Table 16: The U.S. Bone Substitute Market Forecast by Value (2019-2023)
3.3.7 The U.S. Cell Based Matrices Market by Value
Table 17: The U.S. Cell Based Matrices Market by Value (2014-2018)
3.3.8 The U.S. Cell Based Matrices Market Forecast by Value
Table 18: The U.S. Cell Based Matrices Market Forecast by Value (2019-2023)
3.3.9 The U.S. Machined Bone Market by Value
Table 19: The U.S. Machined Bone Market by Value (2014-2018)
3.3.10 The U.S. Machined Bone Market Forecast by Value
Table 20: The U.S. Machined Bone Market Forecast by Value (2019-2023)
3.3.11 The U.S Allograft Bone Market by Value
Table 21: The U.S. Allograft bone Market by Value (2014-2018)
3.3.12 The U.S. Allograft Bone Market Forecast by Value
Table 22: The U.S. Allograft Bone Market Forecast by Value (2019-2023)
3.3.13 The U.S. Platelets Concentrator Market by Value
Table 23: The U.S. Platelets Concentrator Market by Value (2014-2018)
3.3.14 The U.S. Platelets Concentrator Market Forecast by Value
Table 24: The U.S. Platelets Concentrator Market Forecast by Value (2019-2023)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Ageing Population in the U.S.
Table 25: The U.S. Ageing population (2014-2018)
4.1.2 Increasing Healthcare Expenditure in the U.S.
Table 26: The U.S. Healthcare Expenditure per Capita (2014-2018)
4.1.3 Prevalence of Orthopedic Disorders
4.1.4 Increasing Incidences of Sports Injuries and Road Accidents
4.1.5 Rising Incidences of Spinal Fusion Surgeries
4.2 Key Trends and Developments
4.2.1 Emerging Technologies in Orthobiologics
4.2.2 Growing Patients’ Preference for Minimally Invasive Procedures
4.3 Challenges
4.3.1 High Healthcare and Medical Costs
4.2.2 Stringent Medical Regulations
5. Competitive Landscape
5.1 The Global Market
5.1.1 Global Orthobiologics Market Share by Company
Table 27: Global Orthobiologics Market Share by Company (2018)
5.2 The U.S. Market
5.2.1 The U.S. Orthobiologics Market Share by Company
Table 28: The U.S. Orthobiologics Market Share by Company (2018)
5.2.2 Revenue Comparison of Key Players
Table 29: Key Players – Revenue Comparison (2018)
5.2.3 Market Cap Comparison of Key Players
Table 30: Key Players - Market Cap Comparison
6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Business Overview
Table 31: Johnson and Johnson Total Sales by Product Segments (2018)
6.1.2 Financial Overview
Table 32: Johnson and Johnson Total Sales and Net Earnings (2014-2018)
6.1.3 Business Strategies
Table 33: Johnson and Johnson R&D Expenditures (2016-2018)
6.2 Medtronic
6.2.1 Business Overview
Table 34: Medtronic Net Sales by Product Segments (2018)
6.2.2 Financial Overview
Table 35: Medtronic Net Sales and Net Income (2014-2018)
6.2.3 Business Strategies
Table 36: Medtronic R&D Expenditures (2016-2018)
6.3 Stryler Corporation
6.3.1 Business Overview
Table 37: Stryker Corporation Sales by Segment (2018)
6.3.2 Financial Overview
Table 38: Stryker Corporation Net Sales and Net Earnings (2014-2018)
6.3.3 Business Strategies
Table 39: Stryker Corporation R&D Expenditure (2016-2018)
6.4 NuVasive Inc.
6.4.1 Business Overview
Table 40: NuVasive Inc. Revenue by Segment (2018)
6.4.2 Financial Overview
Table 41: NuVasive Inc. Total Revenue and Net Income (2014-2018)
6.4.3 Business Strategies
Table 42: NuVasive Inc. R&D Expenditure (2016-2018)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook